p.91 抽出テキスト

Staphylococcus aureus bacteremia. Pacing Clin Electrophysiol 2010;33:407–413. https:// doi.org/10.1111/j.1540-8159.2009.02565.x 677. Hussein AA, Baghdy Y, Wazni OM, Brunner MP, Kabbach G, Shao M, et al. Microbiology of cardiac implantable electronic device infections. JACC Clin Electrophysiol 2016;2:498–505. https://doi.org/10.1016/j.jacep.2016.01.019 678. Mateos Gaitan R, Boix-Palop L, Munoz Garcia P, Mestres CA, Marin Arriaza M, Pedraz Prieto A, et al. Infective endocarditis in patients with cardiac implantable electronic devices: a nationwide study. Europace 2020;22:1062–1070. https://doi.org/10.1093/ europace/euaa076 679. Arora Y, Perez AA, Carrillo RG. Influence of vegetation shape on outcomes in transvenous lead extractions: does shape matter? Heart Rhythm 2020;17:646–653. https:// doi.org/10.1016/j.hrthm.2019.11.015 680. Esquer Garrigos Z, George MP, Vijayvargiya P, Tan EM, Farid S, Abu Saleh OM, et al. Clinical presentation, management, and outcomes of cardiovascular implantable electronic device infections due to Gram-negative versus Gram-positive bacteria. Mayo Clin Proc 2019;94:1268–1277. https://doi.org/10.1016/j.mayocp.2018.11.029 681. Baman JR, Medhekar AN, Jain SK, Knight BP, Harrison LH, Smith B, et al. Management of systemic fungal infections in the presence of a cardiac implantable electronic device: a systematic review. Pacing Clin Electrophysiol 2021;44:159–166. https://doi.org/10. 1111/pace.14090 682. Krahn AD, Longtin Y, Philippon F, Birnie DH, Manlucu J, Angaran P, et al. Prevention of arrhythmia device infection trial: the PADIT trial. J Am Coll Cardiol 2018;72:3098–3109. https://doi.org/10.1016/j.jacc.2018.09.068 683. Birnie DH, Wang J, Alings M, Philippon F, Parkash R, Manlucu J, et al. Risk factors for infections involving cardiac implanted electronic devices. J Am Coll Cardiol 2019;74: 2845–2854. https://doi.org/10.1016/j.jacc.2019.09.060 684. Ahmed FZ, Blomstrom-Lundqvist C, Bloom H, Cooper C, Ellis C, Goette A, et al. Use of healthcare claims to validate the prevention of arrhythmia device infection trial cardiac implantable electronic device infection risk score. Europace 2021;23:1446–1455. https://doi.org/10.1093/europace/euab028 685. Birnie DH, Healey JS, Wells GA, Ayala-Paredes F, Coutu B, Sumner GL, et al. Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2). Eur Heart J 2018;39:3973–3979. https://doi.org/10.1093/eurheartj/ ehy413 686. Birnie DH, Healey JS, Wells GA, Verma A, Tang AS, Krahn AD, et al. Pacemaker or defibrillator surgery without interruption of anticoagulation. N Engl J Med 2013;368: 2084–2093. https://doi.org/10.1056/NEJMoa1302946 687. Burri H, Starck C, Auricchio A, Biffi M, Burri M, D’Avila A, et al. EHRA expert consensus statement and practical guide on optimal implantation technique for conventional pacemakers and implantable cardioverter-defibrillators: endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), and the Latin-American Heart Rhythm Society (LAHRS). Europace 2021;23:983–1008. https://doi.org/10.1093/europace/euaa367 688. Tarakji KG, Mittal S, Kennergren C, Corey R, Poole JE, Schloss E, et al. Antibacterial envelope to prevent cardiac implantable device infection. N Engl J Med 2019;380: 1895–1905. https://doi.org/10.1056/NEJMoa1901111 689. Frausing M, Nielsen JC, Johansen JB, Jorgensen OD, Gerdes C, Olsen T, et al. Rate of device-related infections using an antibacterial envelope in patients undergoing cardiac resynchronization therapy reoperations. Europace 2022;24:421–429. https://doi.org/ 10.1093/europace/euab207 690. Uslan DZ, Sohail MR, Friedman PA, Hayes DL, Wilson WR, Steckelberg JM, et al. Frequency of permanent pacemaker or implantable cardioverter-defibrillator infection in patients with Gram-negative bacteremia. Clin Infect Dis 2006;43:731–736. https:// doi.org/10.1086/506942 691. Uslan DZ, Sohail MR, St Sauver JL, Friedman PA, Hayes DL, Stoner SM, et al. Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch Intern Med 2007;167:669–675. https://doi.org/10.1001/ archinte.167.7.669 692. Fowler VG Jr, Li J, Corey GR, Boley J, Marr KA, Gopal AK, et al. Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients. J Am Coll Cardiol 1997;30:1072–1078. https://doi.org/10.1016/S0735- 1097(97)00250-7 693. Victor F, De Place C, Camus C, Le Breton H, Leclercq C, Pavin D, et al. Pacemaker lead infection: echocardiographic features, management, and outcome. Heart 1999;81: 82–87. https://doi.org/10.1136/hrt.81.1.82 694. Vilacosta I, Sarria C, San Roman JA, Jimenez J, Castillo JA, Iturralde E, et al. Usefulness of transesophageal echocardiography for diagnosis of infected transvenous permanent pacemakers. Circulation 1994;89:2684–2687. https://doi.org/10.1161/01.CIR.89.6. 2684 695. Narducci ML, Pelargonio G, Russo E, Marinaccio L, Di Monaco A, Perna F, et al. Usefulness of intracardiac echocardiography for the diagnosis of cardiovascular implantable electronic device-related endocarditis. J Am Coll Cardiol 2013;61: 1398–1405. https://doi.org/10.1016/j.jacc.2012.12.041 696. Golzio PG, Errigo D, Peyracchia M, Gallo E, Frea S, Castagno D, et al. Prevalence and prognosis of lead masses in patients with cardiac implantable electronic devices without infection. J Cardiovasc Med (Hagerstown) 2019;20:372–378. https://doi.org/ 10.2459/JCM.0000000000000797 697. Erba PA, Sollini M, Conti U, Bandera F, Tascini C, De Tommasi SM, et al. Radiolabeled WBC scintigraphy in the diagnostic workup of patients with suspected device-related infections. JACC Cardiovasc Imaging 2013;6:1075–1086. https://doi.org/10.1016/j.jcmg. 2013.08.001 698. Lin AY, Saul T, Aldaas OM, Lupercio F, Ho G, Pollema T, et al. Early versus delayed lead extraction in patients with infected cardiovascular implantable electronic devices. JACC Clin Electrophysiol 2021;7:755–763. https://doi.org/10.1016/j.jacep.2020.11.003 699. Le KY, Sohail MR, Friedman PA, Uslan DZ, Cha SS, Hayes DL, et al. Impact of timing of device removal on mortality in patients with cardiovascular implantable electronic device infections. Heart Rhythm 2011;8:1678–1685. https://doi.org/10.1016/j.hrthm. 2011.05.015 700. Durante-Mangoni E, Casillo R, Bernardo M, Caianiello C, Mattucci I, Pinto D, et al. High-dose daptomycin for cardiac implantable electronic device-related infective endocarditis. Clin Infect Dis 2012;54:347–354. https://doi.org/10.1093/cid/cir805 701. Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, et al. Management and outcome of permanent pacemaker and implantable cardioverterdefibrillator infections. J Am Coll Cardiol 2007;49:1851–1859. https://doi.org/10.1016/ j.jacc.2007.01.072 702. Huang X-M, Fu H-X, Zhong L, Cao J, Asirvatham SJ, Baddour LM, et al. Outcomes of transvenous lead extraction for cardiovascular implantable electronic device infections in patients with prosthetic heart valves. Circ Arrhythm Electrophysiol 2016;9:e004188. https://doi.org/10.1161/CIRCEP.116.004188 703. De Ciancio G, Erpelding ML, Filippetti L, Goehringer F, Blangy H, Huttin O, et al. Adherence to diagnostic and therapeutic practice guidelines for suspected cardiac implantable electronic device infections. Arch Cardiovasc Dis 2021;114:634–646. https:// doi.org/10.1016/j.acvd.2021.06.010 704. Viganego F, O’Donoghue S, Eldadah Z, Shah MH, Rastogi M, Mazel JA, et al. Effect of early diagnosis and treatment with percutaneous lead extraction on survival in patients with cardiac device infections. Am J Cardiol 2012;109:1466–1471. https://doi.org/10. 1016/j.amjcard.2012.01.360 705. Starck CT, Schaerf RHM, Breitenstein A, Najibi S, Conrad J, Berendt J, et al. Transcatheter aspiration of large pacemaker and implantable cardioverter-defibrillator lead vegetations facilitating safe transvenous lead extraction. Europace 2020;22: 133–138. https://doi.org/10.1093/europace/euz283 706. Golzio PG, Vinci M, Anselmino M, Comoglio C, Rinaldi M, Trevi GP, et al. Accuracy of swabs, tissue specimens, and lead samples in diagnosis of cardiac rhythm management device infections. Pacing Clin Electrophysiol 2009;32(Suppl 1):S76–S80. https://doi.org/ 10.1111/j.1540-8159.2008.02257.x 707. Nagpal A, Patel R, Greenwood-Quaintance KE, Baddour LM, Lynch DT, Lahr BD, et al. Usefulness of sonication of cardiovascular implantable electronic devices to enhance microbial detection. Am J Cardiol 2015;115:912–917. https://doi.org/10.1016/j. amjcard.2015.01.017 708. Rohacek M, Erne P, Kobza R, Pfyffer GE, Frei R, Weisser M. Infection of cardiovascular implantable electronic devices: detection with sonication, swab cultures, and blood cultures. Pacing Clin Electrophysiol 2015;38:247–253. https://doi.org/10.1111/pace. 12529 709. Chew D, Somayaji R, Conly J, Exner D, Rennert-May E. Timing of device reimplantation and reinfection rates following cardiac implantable electronic device infection: a systematic review and meta-analysis. BMJ Open 2019;9:e029537. https://doi.org/10. 1136/bmjopen-2019-029537 710. Diemberger I, Biffi M, Lorenzetti S, Martignani C, Raffaelli E, Ziacchi M, et al. Predictors of long-term survival free from relapses after extraction of infected CIED. Europace 2018;20:1018–1027. https://doi.org/10.1093/europace/eux121 711. Chua JD, Wilkoff BL, Lee I, Juratli N, Longworth DL, Gordon SM. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Intern Med 2000;133:604–608. https://doi.org/10.7326/0003-4819-133-8- 200010170-00011 712. Kawata H, Pretorius V, Phan H, Mulpuru S, Gadiyaram V, Patel J, et al. Utility and safety of temporary pacing using active fixation leads and externalized re-usable permanent pacemakers after lead extraction. Europace 2013;15:1287–1291. https://doi.org/10. 1093/europace/eut045 713. Perrin T, Maille B, Lemoine C, Resseguier N, Franceschi F, Koutbi L, et al. Comparison of epicardial vs. endocardial reimplantation in pacemaker-dependent patients with device infection. Europace 2018;20:e42–e50. https://doi.org/10.1093/europace/eux111 714. Zucchelli G, Barletta V, Della Tommasina V, Viani S, Parollo M, Mazzocchetti L, et al. Micra pacemaker implant after cardiac implantable electronic device extraction: feasibility and long-term outcomes. Europace 2019;21:1229–1236. https://doi.org/10.1093/ europace/euz160 715. Chung DU, Tauber J, Kaiser L, Schlichting A, Pecha S, Sinning C, et al. Performance and outcome of the subcutaneous implantable cardioverter-defibrillator after transvenous lead extraction. Pacing Clin Electrophysiol 2021;44:247–257. https://doi.org/10.1111/ pace.14157 Downloaded from academic.oup.com/eurheartj/article/44/39/3948/7243107 by guest on 07 October 2026